Social networking docs write more scripts: eMarketing

Share this article:
Physicians involved in social networking communities online tend to write more prescriptions than other physicians, according to a presentation given at CBI's 8th annual Forum on eMarketing.

Even so, Craig Edfort, senior manager, e-marketing, relationship marketing, strategic business development at Novo Nordisk, said that “selling management without hard ROI is a difficult task,” so digital marketers must be prepared to justify paid executions in the social networking realm. 

Edfort added that Sermo, the largest online physicians' network, is “allow[ing] pharma to participate in a very structured role.” Also, physicians that currently use social networks, or are interested in doing so, are primarily men, explained Bonnie Southcott, interactive producer at Toolhouse Design Co. 

Of the physicians using social networks, 68% are male and 32% are female. Seventy percent of male physicians say they are interested in using social networks, compared with 24% of females, said Southcott, adding that podcasts audiences are currently skewing toward young men as well.

In a separate panel, Thomas McDonnell, director of marketing for Shire's ADHD treatment Intuniv, acknowledged the importance of social networks for physicians, but said that pharma should not be providing the networks themselves. “I don't think it's a business proposition for pharma,” he said. “It's not our role to provide that forum. Our role isn't necessarily to facilitate the conversation [between doctors]. We listen to it, but we should be focused on making sure that physicians have top quality information.”

Glen Butcher, director, global online channel strategies at Merck, agreed with McDonnell, and emphasized the importance of offline support, in the form of accurate, up-to-date drug information. Mark Karch, EVP, business development at Physicians Interactive, predicted that e-prescribing will eventually gain traction, noting that the Obama administration is pumping dollars into e-prescribing. “The scale isn't there yet, but it's coming,” he said.
CBI's eMarketing Forum was held in Princeton, NJ, on March 10-11. 
Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Features

Email Newsletters


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?